A quarter of a century after Procter & Gamble developed the fat substitute olestra, the Food and Drug Administration finally approved it. Now a group associated with Ralph Nader, the Center for Science in the Public Interest, is accusing the FDA of beinga corporate lapdog. Hoover fellow Henry I. Miller details an absurdity.

The content of this article is only available in the print edition.
overlay image